Caristo’s novel technology transforms the diagnostic accuracy of routine coronary CT angiograms, a test used to identify patients with suspected heart disease. Using artificial intelligence, our proprietary technology provides unique insights about inflammation in the coronary arteries, the root cause of most heart attacks.
European Society of Cardiology: Coronary computed tomography angiography (CTA) is an established and highly sensitive non-invasive technique to detect obstructive and non-obstructive coronary artery d...
UpToDate: We are pleased to report that Caristo’s new imaging biomarker, the Perivascular Fat Attenuation Index™ (FAI), has been featured in UpToDate’s latest chapter on Noninvasive Coronary Ima...
Caristo Diagnostics is proud to have been part of the bid which secured funding for NCIMI in Oxford. University of Oxford: Innovate UK and industry are to invest more than £17.5 million in the Univer...
MedScape: Rupture of unstable nonobstructive plaque is the underlying cause of most acute coronary syndromes.[1,2] However, imaging tests to identify high-risk plaque features such as thin-cap fibroa...
JAMA: A new protocol to rule out myocardial infarctions (MIs), or heart attacks, in emergency departments using a recently approved high-sensitivity troponin t test was found to be safe and accurat...
GDPR Statement.
For the purpose of contacting you, we will save your email address, phone number and the contents of your message. Should you wish to have these records removed please email: dpo@caristo.com
GDPR Statement.
For the purpose of contacting you, we will save your email address, phone number and the contents of your message. Should you wish to have these records removed please email: dpo@caristo.com